Furthermore, to evaluate the in vivo anti-tumor activity of IL-7-CAR-T cells, we generated xenograft tumor-bearing mice by subcutaneously injecting HCC827/Luc cells into 7-week-old male NPG mice. This evidence concerns the gene IL7 and neoplasm.